Last update: July 1, 2015
Minimal risk for breastfeeding and infant.
It is excreted into breast milk in clinically non-significant amount.
Not effects on the infant's physical and psychomotor development at both short or long-term were found.
Variable levels of Prolactin secretion (increment or lowering), which were non-significant, were found after the use of Trazodone.
Because there is less experience published than with other drugs of the same pharmacological group, it should be preferred the use of an alternative drug that is known to be safer in the neonatal period or prematurity.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM